L-Carnosine: The Dipeptide With a Bioavailability Problem

L-carnosine is a naturally occurring dipeptide of beta-alanine and histidine, concentrated in skeletal muscle and brain. It is one of the few genuine peptides sold as a common supplement, and it comes with a specific pharmacologic complication that most marketing does not mention.

This guide situates L-Carnosine within the broader field of peptide therapy and is written for clinicians. It is clinical education, not medical advice, and nothing here should be read as a treatment recommendation or protocol.

What carnosine does

Carnosine is present at high concentration in skeletal muscle, where its best-established role is pH buffering. Intense exercise generates hydrogen ions, and carnosine's histidine imidazole ring buffers them within the physiological range, delaying the acidification that contributes to fatigue.

It also has antioxidant activity and chelates transition metals such as copper and iron that catalyse free radical formation.

Its most interesting property for aging biology is antiglycation. Glycation is the non-enzymatic reaction of sugars with proteins, producing advanced glycation end products (AGEs) that accumulate in long-lived tissues including collagen, lens protein and vessel walls, contributing to stiffness and dysfunction. Carnosine can act as a sacrificial target, reacting with reactive carbonyls before they damage functional proteins. This mechanism underlies most anti-aging claims made for it — and is discussed in our glycation guide.

The problem with taking it orally

Human serum contains carnosinase, an enzyme that hydrolyzes carnosine into its constituent amino acids. It is highly active, and after an oral dose, circulating carnosine is degraded rapidly — substantially within a short window.

This creates a genuine gap between the biology and the supplement. Carnosine's activities are real, and the ability of an oral dose to deliver intact carnosine to tissue at meaningful concentration is seriously limited by an enzyme specifically evolved to break it down.

There is a notable species difference worth knowing: rodents have much lower serum carnosinase activity than humans. Animal studies showing benefits from carnosine supplementation may therefore substantially overstate what an equivalent human dose achieves — a translation problem that applies to a considerable portion of the carnosine literature.

This is why sports nutrition uses beta-alanine instead. Beta-alanine is the rate-limiting precursor for carnosine synthesis within muscle. Supplying the precursor lets muscle build its own carnosine internally, where carnosinase cannot reach it. Beta-alanine has a considerably better evidence base for raising muscle carnosine and improving high-intensity exercise performance than oral carnosine does.

Where the evidence stands

For exercise performance, the evidence supports raising muscle carnosine content, and beta-alanine is the established route.

For aging and glycation, the mechanistic rationale is sound and human clinical outcome data are limited. Studies have examined carnosine in diabetic complications, cognitive measures and other contexts with mixed and generally preliminary results.

Carnosine has also been studied in eye conditions using N-acetylcarnosine eye drops for cataract, where topical delivery to the target tissue avoids the serum carnosinase problem entirely. That work remains contested and has not established the compound as an effective cataract treatment.

Carnosine is well tolerated, with no significant safety concerns at typical supplement doses.

Status

L-carnosine is sold as a dietary supplement and is not an approved drug for any condition. It is one of the more benign entries in this formulary from a safety standpoint.

The accurate summary for a patient: genuine biology, a real antiglycation mechanism, and a bioavailability limitation that means oral carnosine likely delivers less than its marketing implies. Where the goal is muscle carnosine specifically, beta-alanine is the better-evidenced approach.